Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| COATS LONNEL | Nov 16, 2023 | Buy | 90,000 | $1.0533 | $95,000 |
| Amouyal Philippe | Nov 13, 2023 | Buy | 200,000 | $1.0076 | $200,000 |
| COATS LONNEL | Nov 10, 2023 | Buy | 10,000 | $1.01 | $10,000 |
| DEBBANE RAYMOND | Oct 12, 2023 | Buy | 148,820 | $1.0335 | $150,000 |
| DEBBANE RAYMOND | Oct 11, 2023 | Buy | 342,874 | $1.0814 | $370,000 |
| DEBBANE RAYMOND | Oct 10, 2023 | Buy | 508,306 | $1.1398 | $580,000 |
| WADE JEFFREY L | Sep 14, 2023 | Buy | 10,000 | $1.38 | $14,000 |
| McDermott Wendy | Aug 4, 2023 | Buy | 6,000 | $1.84 | $11,000 |
| COATS LONNEL | Jun 29, 2023 | Buy | 10,000 | $2.16 | $22,000 |
| COATS LONNEL | Jun 26, 2023 | Buy | 10,000 | $2.1792 | $22,000 |
| COATS LONNEL | Jun 22, 2023 | Buy | 40,000 | $2.31 | $92,000 |
| Artal Group S.A. | Jun 5, 2023 | Buy | 27,775,050 | $2.6 | $72M |
What's the latest insider transaction for Lexicon Pharmaceuticals?
The most recent insider transaction for Lexicon Pharmaceuticals was conducted by COATS LONNEL, who sold 90,000 shares on November 16, 2023 at a price of $1.05 per share.
Which insider bought the most LXRX stock over the last two years?
Artal Group S.A. has bought the most LXRX stock in the last 2 years, with a total value of $72M.
What is the total value of insider transactions for Lexicon Pharmaceuticals (LXRX) in the last 2 years?
According to our estimates, the total value of insider transactions for Lexicon Pharmaceuticals in the last 2 years is positive, amounting to $74M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Lexicon Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Lexicon Pharmaceuticals have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
